Neuroendoscopy market seen reaching $1.09 billion by 2030

The neuroendoscopy market is projected to grow from $0.83 billion in 2026 to $1.09 billion by 2030, according to The Business Research Company. Rising brain tumor cases, demand for minimally invasive brain surgery and broader adoption of advanced imaging are driving the outlook.

Why it matters: - Neuroendoscopy is gaining ground as hospitals and neurosurgeons look for procedures that reduce tissue damage, shorten recovery and lower complication risk. - The market outlook points to steady demand for minimally invasive neurological treatments, especially as imaging and surgical tools improve. - The forecast suggests the field could see broader use in pediatric neurosurgery, flexible scopes and high-definition visualization systems.

What happened: - The Business Research Company released a 2026 market report on neuroendoscopy with a forecast through 2030. - The report estimates the market will rise from $0.83 billion in 2026 to $1.09 billion by 2030. - The report projects a 6.8% compound annual growth rate over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Neuroendoscopy uses specialized endoscopic instruments through small incisions to diagnose and treat neurological conditions, including brain tumors, epilepsy and cerebrovascular disorders. - The approach is positioned as a less invasive alternative to open brain surgery. - The method is designed to improve surgical accuracy while minimizing damage to surrounding tissue. - The report links market growth to rising neurological disorder rates, wider adoption of endoscopic surgery, advances in visualization technology and more specialized neurosurgery centers. - The report also points to increasing preference for minimally invasive brain surgery, more investment in surgical imaging, growth in pediatric neurosurgery services and ongoing innovation in instruments and techniques. - Brain tumor incidence is a major demand driver. - Cancer Australia reported about 1,924 new brain cancer cases in 2023, including 1,183 in males and 741 in females. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says the 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report is available as a free sample and as the full market report.

Between the lines: - The forecast reflects a broader shift toward less invasive neurological care, where smaller access points and better imaging can support faster recovery. - The emphasis on pediatric use and flexible scopes suggests the market is moving beyond routine adult procedures. - Stronger growth in Asia-Pacific likely reflects expanding neurosurgical capacity and higher healthcare investment rather than mature-market replacement demand.

What's next: - The report expects wider adoption of minimally invasive neuroendoscopic procedures in the coming years. - High-definition and 4K visualization systems are expected to gain more use. - Demand for flexible neuroendoscopes is expected to rise. - Providers are likely to place more focus on precision and safety as neuroendoscopic tools and techniques continue to improve. - The market is forecast to keep expanding through 2030, with revenue reaching $1.09 billion.